Optimization of key parameters, such as modifying the PBA moiety and utilizing the anionic Lipo-ORG for lymphatic delivery, resulted in suppressed tumor growth and metastasis, extended survival, and synergistic effects with PD-L1 blockade in a B16-OVA tumor model (117). Here, CD274 is linked to neoplasm.